Adjuvant Therapy for Renal Cell Carcinoma

被引：5
|
作者：
Pinto, Alvaro [1 ]
机构：
[1] Univ Hosp La Paz IdiPAZ, Dept Med Oncol, Madrid 28046, Spain
来源：
CLINICAL GENITOURINARY CANCER | 2014年 / 12卷 / 06期
关键词：
Clinical trials; Immune therapy; Relapse risk; Risk reduction; Targeted therapy; POSTOPERATIVE PROGNOSTIC NOMOGRAM; RADICAL NEPHRECTOMY; PHASE-III; HIGH-RISK; STAGE-II; RANDOMIZED-TRIAL; CANCER; INTERFERON; RECURRENCE; SURVIVAL;
D O I：
10.1016/j.clgc.2014.06.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In the past few years, several targeted therapies have been approved by the U.S. Food and Drug Administration for the treatment of advanced renal cell carcinoma. This has led to an improvement in the progression-free survival and quality of life for these patients. Nevertheless, the use of these and other therapies in the adjuvant setting has failed to demonstrate a clear benefit. Immune therapies and hormonal or targeted therapies have been studied in this indication, and there are clinical trials currently enrolling patients with high risk of relapse. This article reviews the available data and the ongoing trials exploring the role of adjuvant therapy for kidney cancer.
引用
收藏
页码：408 / 412
页数：5
相关论文
共 50 条
  • [41] Eyelid-sparing adjuvant radiation therapy for renal cell carcinoma
    Kurli, Madhavi
    Finger, Paul T.
    Schneider, Susan
    Tena, Lawrence B.
    [J]. OPHTHALMOLOGICA, 2006, 220 (03) : 198 - 200
  • [42] Adjuvant Therapy in Renal Cell Carcinoma: Are we ready for prime time?
    Wang, Luke L.
    Saidian, Ava
    Pan, Elizabeth
    Panian, Justine
    Derweesh, Ithaar H.
    McKay, Rana R.
    [J]. KIDNEY CANCER, 2023, 7 (01) : 1 - 11
  • [43] Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma
    Ismail-Zade, RS
    Zhavrid, EA
    Potapnev, MP
    [J]. PEDIATRIC BLOOD & CANCER, 2005, 44 (07) : 679 - 681
  • [44] Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?
    Mollica, Veronica
    Rizzo, Alessandro
    Di Nunno, Vincenzo
    Santoni, Matteo
    Cheng, Liang
    Lopez-Beltran, Antonio
    Scarpelli, Marina
    Cimadamore, Alessia
    Montironi, Rodolfo
    Massari, Francesco
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (03) : 1582 - +
  • [45] Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma
    Geller, JI
    Dome, JS
    [J]. PEDIATRIC BLOOD & CANCER, 2006, 46 (04) : 527 - 527
  • [46] Adjuvant Therapy in Renal Cell Carcinoma-Past, Present, and Future
    Janowitz, Tobias
    Welsh, Sarah J.
    Zaki, Kamarul
    Mulders, Peter
    Eisen, Tim
    [J]. SEMINARS IN ONCOLOGY, 2013, 40 (04) : 482 - 491
  • [47] Adjuvant therapy in renal cell carcinoma: is resection still solely enough?
    El Gharib, Khalil
    [J]. FUTURE ONCOLOGY, 2021, 17 (06) : 633 - 636
  • [48] Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions
    Kazarian, Austin G.
    Chawla, Neal S.
    Muddasani, Ramya
    Pal, Sumanta K.
    [J]. KIDNEY CANCER, 2021, 5 (01) : 9 - 20
  • [49] Adjuvant therapy with activated T cells for patients with renal cell carcinoma
    LeFever, A
    Treisman, J
    Hanson, J
    [J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S20 - S21
  • [50] Adjuvant therapy in renal-cell carcinoma: Is it prime time yet?
    Dimitriadis, John
    Bamias, Aristotelis
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S360 - S362
12345